Kala Hill
Director, Value Evidence Strategy Team Leader, Core Oncology @ Merck
About Kala Hill
Kala Hill serves as the Director and Value Evidence Strategy Team Leader for Core Oncology at Merck, where she has worked since 2021. She has extensive experience in health economics and market access, having held positions at various companies including TAIHO ONCOLOGY INC and Celldex Therapeutics.